Macular Degeneration Research

Macular Degeneration Research, a BrightFocus Foundation program, accelerates groundbreaking research exploring the root causes of and prevention strategies and treatments for macular degeneration, a leading cause of vision loss.

An older woman embraces an older man from behind. They are looking at each other and smiling.

Our Impact: Making a Difference

Macular Degeneration Research is currently supporting a global portfolio of 44 active scientific projects, a more than $14 million investment. Our grants are vetted through a rigorous evaluation process by the world’s top scientists and clinicians who serve on our scientific review committee.

With our grants, scientists are investigating hundreds of ideas to prevent, treat, and cure macular degeneration.

a decorative icon

44

Active research grants we’re supporting worldwide

a decorative icon

145

Scientists currently supported through our grants

a decorative icon

More than $56 million

Invested in macular degeneration research since inception.

News loudspeaker icon.

Recent News

News & Breakthroughs

Discover bold ideas and the latest research advancements in our quest to end macular degeneration.
An older man sits on a couch with a glass of water in one hand and a pill pinched between the thumb and forefinger of the other, bringing the pill close to his mouth

New Supplement to Prevent Macular Degeneration Inspires Deeper Search for Cures

A Macular Degeneration Research-funded scientist launched a supplement based on a link he discovered between the eye disease and Parkinson’s disease. Now he’s continuing research in the hopes of finding novel cures.

Daisy Shu, PhD
Macular Degeneration Research grant recipient Daisy Shu, PhD

Transforming Macular Degeneration Care With Long-Acting Treatment

With funding from Macular Degeneration Research, Dr. Daisy Shu is exploring advanced drug delivery systems that release medicine slowly over time. This innovative approach could reduce the number of injections needed for macular degeneration while maintaining vision-saving results.

Senior woman having an eye exam with her optometrist.

How Targeting a Molecular ‘Switch’ Could Inspire New Macular Degeneration Treatments

A researcher funded by BrightFocus’ Macular Degeneration Research is zeroing in on a protein that damages eye cells in the early stages of dry age-related macular degeneration, offering insights that could lead to new treatments.

Portrait of smiling senior man with eyeglasses.

How Better Models of Macular Degeneration Could Help Prevent Vision Loss

Most experimental models that researchers use to study macular degeneration fall short. BrightFocus Macular Degeneration Research grant recipient Dr. Brittany Carr aims to change that.

An incredibly mesmerizing abstract representation of an eye, featuring vivid colors and intricate patterns in detail.

Is This the Next Best Thing to Regrowing a New Retina?

A BrightFocus Macular Degeneration Research-funded scientist is investigating a new regeneration technique to restore key cells that are wiped out in late-stage age-related macular degeneration.

A microscopic image of cultured retinal pigment epithelial cells.

Turning Back the Biological Clock on Aged and Injured Eye Cells

A de-aging technique offers hope for halting damage in early macular degeneration.

Mature man squinting using laptop, looking at screen.

New Research Links Blue Light to Macular Degeneration Risk, Antioxidants May Offer Hope

Blue light ​may​ damage the eyes by causing unstable “free radicals” to form, ​which increases the risk of​ age-related macular degeneration. BrightFocus-funded research offers a potential way to protect the eyes from blue light.

Dr. Miguel Flores-Bellver in his laboratory. The screen behind him shows retinal photoreceptor cells viewed under a microscope.

Exosomes: The New Frontier in Early Detection of Macular Degeneration

Motivated by his family’s experience with eye diseases, Dr. Miguel Flores-Bellver is searching for new biomarkers of age-related macular degeneration. 

Sweet little girl with her mother and grandmother.

Investigational Eye Drop for Wet Age-Related Macular Degeneration Enters Phase 2 Clinical Trial

A clinical trial for an investigational eye drop to treat wet age-related macular degeneration is seeking eligible participants for enrollment.

View All
An icon depicting a question mark in a speech bubble

Why It Matters

Why Research Matters

an older man sits in a chair reading something from a piece of paper while an older woman leans over his shoulder to read it as well.

Advanced macular degeneration is a leading cause of irreversible blindness and visual impairment in the world.

Approximately 200 million people worldwide are thought to be living with macular degeneration–a number expected to reach 288 million by 2040.

Macular Degeneration Research invests in groundbreaking research worldwide to defeat macular degeneration, pursuing innovative treatments, preventative measures, and a cure.

Our Approach to Research

Macular Degeneration Research takes a 360-degree approach to funding innovative scientific research worldwide to defeat macular degeneration. By examining the disease from all angles–from the impact of diet and nutrition to cell regeneration– we leave no stone unturned to discover improved treatments, prevention strategies, and a cure.

Our Approach

Macular Chats

Join an upcoming audio conversation with scientists and vision experts about treatments, research breakthroughs, and tips for living with low vision.

Sign Up

Monitor Your Vision at Home

The Amsler grid is an at-home eye test to help detect early signs of retinal disease such as age-related macular degeneration (AMD). If you have already been diagnosed with AMD, the Amsler grid will help you detect the progression of dry AMD to the wet form of the disease at an early, treatable stage.

Get the Amsler Grid

Slow Dry AMD With the AREDS2 Supplement

Certain vitamins can help slow the progression of age-related macular degeneration (AMD) and decrease your risk of losing central vision. But it’s important to find the right vitamins since many are marketed for eye health but only a few have formulas that have proven effective.

Learn More
Designed logo for Macular Chats with the name of the program and an icon of an eye wearing headphones to represent this audio series.
Man covers his left eye while using the Amsler gird printed on a piece of paper as a form of at-home macular degeneration testing.
Woman counts a handful of medication.
Resources icon.

Resources

We’re here for you.

Explore articles, videos, brochures, and more to help you understand and manage symptoms, treatments, and the latest research toward a cure.
Portrait of a senior couple embracing at home.
Macular Chats

Supporting the Supporters: Care Partners in Vision Loss

In recognition of National Caregivers Month, this episode explores the vital role of those who support individuals living with vision loss—whether family members, professionals, or volunteers.

A close-up view of a researcher using a microscope. The person, wearing white gloves, is adjusting a glass slide with a specimen under the microscope's lens
Macular Chats

Understanding Stem Cell Research for Macular Degeneration

Dr. Jeffrey Stern and Dr. Sally Temple, Principal Investigators and Co-Founders of the Neural Stem Cell Institute, will explain what stem cells are and share the latest updates from clinical trials.

A photo of Dave and Leanna
Story

Finding Purpose and Community Through Supporting Research

Dave and Leanna Palmer share their commitment to supporting Macular Degeneration Research.

A decorative photo of a human eye. The iris is overlayed with neon, technical-looking patterns
Expert Information

How Retinal and Brain Implants Restore Partial Sight

Artificial vision systems utilizing these technologies show promise for individuals with profound vision loss in early trials.

Close up of an older woman's eye.
Macular Chats

Saving Sight: How Long-Term Treatment Helps Slow Geographic Atrophy

Join Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue, and supporting daily visual function.

A researcher working with a test tube.
Macular Chats

Innovative Science Driving Macular Degeneration Progress

Dr. Diane Bovenkamp highlights several of this year’s groundbreaking projects and explain how they’re driving progress in early detection, risk reduction, new treatments—and ultimately, a cure.

Alternative medicine herbal organic capsule with vitamin E omega 3 fish oil, mineral, drug with herbs leaf natural supplements for healthy good life.
Macular Chats

Vitamins and Supplements for Retinal Health

Dr. Brian McKay and Dr. Murray Brilliant discuss the widely used AREDS2 nutrient formula and exciting new research into L-DOPA, a naturally occurring compound that may offer a stronger role in maintaining retinal health.

A joyful elderly woman with white hair and glasses smiles warmly outdoors during sunset in a natural, serene setting.
Expert Information

Emerging Treatments Offer New Hope for Dry and Wet Age-Related Macular Degeneration

Promising new treatments in late-stage clinical trials could transform how we treat age-related macular degeneration.

Current treatments for wet age-related macular degeneration (AMD) require eye injections approximately every 4 – 8 weeks. Learn about a potential new treatment that may require less frequent injections.
Downloadable Resource

Treatments for Macular Degeneration

Find information on treatment options for dry and wet age-related macular degeneration.

Document with magnifying glass icon.

Grants & Scientists

Dr. Zhichao Wu with lab equipment

Apply for a Research Grant

Macular Degeneration Research provides research funds for U.S. domestic and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment for macular degeneration.